Biocure Technology Inc.
CURE.CN
Get informed when a big investor buys or sells
+ FollowMarket Cap$408.02K
Close$
Share Statistics
| Market cap | $408,018.00 |
|---|---|
| Enterprise Value | $408,447.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.18 |
| Beta | 2.69 |
| Outstanding Shares | 12,147,800 |
Return
| Return on Equity | -17.44% |
|---|---|
| Return on Assets | -12.16% |
| Return on Invested Capital | -16.12% |
Valuation & Multiples
| P/E Ratio | -0.08 |
|---|---|
| PEG | -1.23 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.73 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Biocure Technology Inc.
3 employees
CEO: Yee Sing Cheng Biocure Technology Inc., along with its subsidiary, is dedicated to the development and market introduction of biopharmaceutical technologies, particularly those leveraging recombinant proteins and ranibizumab. The company's therapeutic ...